COMP <GO>
ALKS vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Alkermes plc (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ALKS 5
— MRK 9
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $45.34 (-0.07%) • MKT CAP: $7.61B
options-implied-move
7.10%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALKS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALKS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 86.70% | 74.80% | +11.90 | ALKS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.00% | 20.70% | -6.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.1x | 15.3x | +9.80 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 6.31% | 3.42% | +2.89 | ALKS | /fcf-yield <GO> |
| Operating Margin | 17.20% | 34.30% | -17.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | 16.40% | 28.10% | -11.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -5.20% | 1.30% | -6.50 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.03 | 5.19 | +2.84 | ALKS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.10% | 6.60% | +0.50 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 56.9 | +4.27 | ALKS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.92 | +0.13 | ALKS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.3x | 18.4x | +10.90 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.61B | $361.02B | -$353.41B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALKS REV | MRK REV | ALKS GROSS % | MRK GROSS % | ALKS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.48B | $65.01B | 86.7% | 74.8% | $480.3M | $12.36B |
| FY 2024 | $1.56B | $64.17B | 84.2% | 76.3% | $405.6M | $18.10B |
| FY 2023 | $1.66B | $60.12B | 44.0% | 44.0% | $326.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALKS // BETA 1.05
MRK // BETA 0.92